The Reemerging Field of Psychedelic Research| Anthony P. Bossis, PhD on Doctor’s Farmacy with Mark Hyman, MD

Key Takeaways

  • Medicinal psychedelics are used in a very specific, controlled setting
  • Controlled psychedelic experiences can generate significant changes, even decades later
  • Drugs acts as a catalyst for the experience, but the experience changes us and calibrates who we are
  • Patients often report a high spiritual experience about the love of self and others as the core of existence
  • One dose of psychedelics often recalibrates feelings about self and death among palliative care patients
  • Psychedelics are being researched for therapeutic use in the recovery of alcoholism, addiction, and PTSD

Introduction

Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine. He is currently conducting FDA-approved clinical trials in the reemerging field of psychedelic research and is investigating the effects of psilocybin.

In the sneak peek of this episode, Dr. Mark Hyman sits down with Anthony P. Bossis, PhD to discuss the resurgence in psychedelic research and its future implications for medicine.  

Host: Mark Hyman, MD (@drmarkhyman

Medicinal Uses of Psychedelics

  • This is not a party! Medicinal psychedelics are used in a very specific, controlled setting
  • Today’s research methods build on pioneers of the 1960s
  • Psychedelics are being researched for use in the recovery of alcoholism, addiction, and PTSD
  • Currently, palliative care studies are being conducted on cancer patients who fear death

Dosing of Psychedelics

  • Psychedelics are only taken in one dose
  • Experience can generate significant changes, even decades later
  • Drugs act as a catalyst for the experience, but the experience changes us and calibrates who we are

How Do Psychedelic Palliative Studies Work?

  • Patients are prepped on what is going to happen for weeks prior to the psychedelic experience
  • A guide from the research team accompanies the patient the entire time to provide the patient with comfort, hand-holds them, and takes them to the restroom, etc.
  • Guide rapport and self-trust are the keys since sessions are guided and can be tough
  • Patients are instructed to let go and give in to the unfolding changes without resistance
  • Patients are encouraged to move into the uncomfortable experiences and work through it
  • Avoiding what comes during psychedelic use is what induces anxiety

What Happens After The Study?

  • Patients return for integration meetings with clinicians to process and unpack the experience
  • One dose of psychedelics often recalibrates their feelings about self and death
  • Love is a common theme that comes up across patients
  • Patients often report a high spiritual experience about the love of self and others as the core of existence
  • Other major topics: internal forgiveness is a big topic, solar systems, autobiographical experiences, sometimes reliving of past traumas
Doctor's Farmacy with Mark Hyman, MD : , , , ,
Notes By Maryann

More Notes on these topics

Top Insights and Tactics From

31 Best Podcasts of All Time

FREE when you join over 12,000 subscribers to the
Podcast Notes newsletter

No Thanks